1. Home
  2. STVN vs CGNX Comparison

STVN vs CGNX Comparison

Compare STVN & CGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • CGNX
  • Stock Information
  • Founded
  • STVN 1949
  • CGNX 1981
  • Country
  • STVN Italy
  • CGNX United States
  • Employees
  • STVN N/A
  • CGNX N/A
  • Industry
  • STVN Containers/Packaging
  • CGNX Industrial Machinery/Components
  • Sector
  • STVN Consumer Discretionary
  • CGNX Industrials
  • Exchange
  • STVN Nasdaq
  • CGNX Nasdaq
  • Market Cap
  • STVN 5.7B
  • CGNX 5.3B
  • IPO Year
  • STVN 2021
  • CGNX 1989
  • Fundamental
  • Price
  • STVN $21.77
  • CGNX $25.76
  • Analyst Decision
  • STVN Buy
  • CGNX Buy
  • Analyst Count
  • STVN 6
  • CGNX 12
  • Target Price
  • STVN $25.08
  • CGNX $44.42
  • AVG Volume (30 Days)
  • STVN 338.6K
  • CGNX 3.7M
  • Earning Date
  • STVN 05-08-2025
  • CGNX 04-30-2025
  • Dividend Yield
  • STVN 0.27%
  • CGNX 1.28%
  • EPS Growth
  • STVN N/A
  • CGNX N/A
  • EPS
  • STVN 0.45
  • CGNX 0.62
  • Revenue
  • STVN $1,143,012,735.00
  • CGNX $914,515,000.00
  • Revenue This Year
  • STVN $8.60
  • CGNX $8.48
  • Revenue Next Year
  • STVN $10.43
  • CGNX $10.78
  • P/E Ratio
  • STVN $48.77
  • CGNX $40.30
  • Revenue Growth
  • STVN 1.72
  • CGNX 9.19
  • 52 Week Low
  • STVN $16.56
  • CGNX $22.67
  • 52 Week High
  • STVN $28.77
  • CGNX $53.13
  • Technical
  • Relative Strength Index (RSI)
  • STVN 56.72
  • CGNX 42.88
  • Support Level
  • STVN $21.13
  • CGNX $22.85
  • Resistance Level
  • STVN $22.46
  • CGNX $25.73
  • Average True Range (ATR)
  • STVN 1.33
  • CGNX 1.44
  • MACD
  • STVN 0.12
  • CGNX 0.27
  • Stochastic Oscillator
  • STVN 86.32
  • CGNX 74.73

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About CGNX Cognex Corporation

Cognex Corp provides machine vision products that help automate manufacturing processes. The firm's products include vision software, vision systems, vision sensors, and ID products. Vision software combines vision tools with a customer's cameras and peripheral equipment and can help with several vision tasks, including part location, identification, measurement, and robotic guidance. Vision systems combine a camera, processor, and vision software into a single package. Vision sensors deliver simple, low-cost solutions for common vision applications, such as checking the size of parts. ID products read codes that have been applied to items during the manufacturing process. Cognex generates the maximum proportion of its sales in the United States and Europe.

Share on Social Networks: